{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:29:39Z","timestamp":1787696979790,"version":"build-2784847793"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,30]]},"DOI":"10.7759\/cureus.68231","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T17:01:18Z","timestamp":1725037278000},"source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness of Vitamin E in Treatment of Antipsychotic-Induced Tardive Dyskinesia and Extrapyramidal Symptoms: A Case Report"],"prefix":"10.7759","author":[{"given":"Muhanad","family":"Elnoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Ali","family":"Bokhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghana","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idriss A","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"[Recent research trends in diagnosis, treatment, and prevention of drug-induced extrapyramidal symptoms seen in psychiatric patients]","volume":"16","author":"Inada T","year":"1996","unstructured":"Inada T. [Recent research trends in diagnosis, treatment, and prevention of drug-induced extrapyramidal symptoms seen in psychiatric patients]. Nihon Shinkei Seishin Yakurigaku Zasshi. 1996, 16:181-5.","journal-title":"Nihon Shinkei Seishin Yakurigaku Zasshi"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/14.2.291","article-title":"Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms","volume":"14","author":"Lohr JB","year":"1988","unstructured":"Lohr JB, Cadet JL, Lohr MA, et al.. Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms. Schizophr Bull. 1988, 14:291-6. 10.1093\/schbul\/14.2.291","journal-title":"Schizophr Bull"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(01)00364-5","article-title":"Mechanisms underlying the protective potential of \u03b1-tocopherol (vitamin E) against haloperidol-associated neurotoxicity","volume":"26","author":"Post A","year":"2002","unstructured":"Post A. Mechanisms underlying the protective potential of \u03b1-tocopherol (vitamin E) against haloperidol-associated neurotoxicity. Neuropsychopharmacology. 2002, 26:397-407. 10.1016\/S0893-133X(01)00364-5","journal-title":"Neuropsychopharmacology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(99)00015-2","article-title":"The effect of vitamin E addition to acute neuroleptic treatment on the emergence of extrapyramidal side effects in schizophrenic patients: an open label study","volume":"9","author":"Dorfman-Etrog P","year":"1999","unstructured":"Dorfman-Etrog P, Hermesh H, Prilipko L, et al.. The effect of vitamin E addition to acute neuroleptic treatment on the emergence of extrapyramidal side effects in schizophrenic patients: an open label study. Eur Neuropsychopharmacol. 1999, 9:475-7. 10.1016\/S0924-977X(99)00015-2","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref5","article-title":"The treatment of tardive dyskinesia and tardive dystonia","volume":"61 Suppl 4","author":"Simpson GM","year":"2000","unstructured":"Simpson GM. The treatment of tardive dyskinesia and tardive dystonia. J Clin Psychiatry. 2000, 61 Suppl 4:39-44.","journal-title":"J Clin Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/BF01880556","article-title":"Vitamin E in extrapyramidal disorders","volume":"15","author":"Bischot L","year":"1993","unstructured":"Bischot L, Van den Brink G, Porsius AJ. Vitamin E in extrapyramidal disorders. Pharm World Sci. 1993, 15:146-50. 10.1007\/BF01880556","journal-title":"Pharm World Sci"},{"key":"ref7","article-title":"A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia","volume":"57","author":"Lohr JB","year":"1996","unstructured":"Lohr JB, Caligiuri MP. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia. J Clin Psychiatry. 1996, 57:167-73.","journal-title":"J Clin Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.56.9.836","article-title":"Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study #394 Study Group","volume":"56","author":"Adler LA","year":"1999","unstructured":"Adler LA, Rotrosen J, Edson R, et al.. Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study #394 Study Group. Arch Gen Psychiatry. 1999, 56:836-41. 10.1001\/archpsyc.56.9.836","journal-title":"Arch Gen Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-2222-6","article-title":"Combined treatment of ascorbic acid or alpha-tocopherol with dopamine receptor antagonist or nitric oxide synthase inhibitor potentiates cataleptic effect in mice","volume":"181","author":"Lazzarini M","year":"2005","unstructured":"Lazzarini M, Salum C, Del Bel EA. Combined treatment of ascorbic acid or alpha-tocopherol with dopamine receptor antagonist or nitric oxide synthase inhibitor potentiates cataleptic effect in mice. Psychopharmacology (Berl). 2005, 181:71-9. 10.1007\/s00213-005-2222-6","journal-title":"Psychopharmacology (Berl)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000209.pub3","article-title":"Vitamin E for antipsychotic-induced tardive dyskinesia","volume":"1","author":"Soares-Weiser K","year":"2018","unstructured":"Soares-Weiser K, Maayan N, Bergman H. Vitamin E for antipsychotic-induced tardive dyskinesia. Cochrane Database Syst Rev. 2018, 1:CD000209. 10.1002\/14651858.CD000209.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1345\/aph.19213","article-title":"Clozapine-associated extrapyramidal reaction","volume":"34","author":"Elliott ES","year":"2000","unstructured":"Elliott ES, Marken PA, Ruehter VL. Clozapine-associated extrapyramidal reaction. Ann Pharmacother. 2000, 34:615-8. 10.1345\/aph.19213","journal-title":"Ann Pharmacother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050784","article-title":"Haloperidol-induced extrapyramidal reaction: lack of protective effect by vitamin E","volume":"140","author":"Eranti VS","year":"1998","unstructured":"Eranti VS, Gangadhar BN, Janakiramaiah N. Haloperidol-induced extrapyramidal reaction: lack of protective effect by vitamin E. Psychopharmacology (Berl). 1998, 140:418-20. 10.1007\/s002130050784","journal-title":"Psychopharmacology (Berl)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1179\/1476830514Y.0000000139","article-title":"Vitamin E and essential polyunsaturated fatty acids supplementation in schizophrenia patients treated with haloperidol","volume":"19","author":"Bo\u0161kovi\u0107 M","year":"2016","unstructured":"Bo\u0161kovi\u0107 M, Vovk T, Kopriv\u0161ek J, Plesni\u010dar BK, Grabnar I. Vitamin E and essential polyunsaturated fatty acids supplementation in schizophrenia patients treated with haloperidol. Nutr Neurosci. 2016, 19:156-61. 10.1179\/1476830514Y.0000000139","journal-title":"Nutr Neurosci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/JEP.S63553","article-title":"Experimental treatment of antipsychotic-induced movement disorders","volume":"8","author":"Shireen E","year":"2016","unstructured":"Shireen E. Experimental treatment of antipsychotic-induced movement disorders. J Exp Pharmacol. 2016, 8:1-10. 10.2147\/JEP.S63553","journal-title":"J Exp Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/291429-effectiveness-of-vitamin-e-in-treatment-of-antipsychotic-induced-tardive-dyskinesia-and-extrapyramidal-symptoms-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T17:01:22Z","timestamp":1725037282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/291429-effectiveness-of-vitamin-e-in-treatment-of-antipsychotic-induced-tardive-dyskinesia-and-extrapyramidal-symptoms-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.68231","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,30]]}}}